Abstract
We hypothesized that locally administrated β-adrenoreceptor agonist can modulate the inflammatory nociceptive parameters in carrageenan (CG)-induced peripheral inflammatory pain. This study was therefore aimed to assess the preventive and therapeutic effects of a β-agonist, dobutamine, by investigating its pretreatment and posttreatment actions on the inflammation-induced hypersensitivities (thermal hyperalgesia, mechanical allodynia) to cutaneous stimulation, edema, and several biochemical oxidant and anti-oxidant parameters in a rat model of CG-induced hind paw inflammation. Effects of dobutamine were compared with those of esmolol, a β-adrenoreceptor antagonist. CG injection to healthy rats lowered the thermal latencies (from 10.1 ± 0.2 to 4.9 ± 0.1 s) and mechanical thresholds (from 32.9 ± 0.5 to 18.9 ± 1.3 g) and caused the hyperalgesia and allodynia. In CG-induced inflamed paws, while intraplantar esmolol treatment (1 mg) produced significant decreases in latencies (4.1 ± 0.1 s) and thresholds (15.2 ± 2.4 g), dobutamine (1 mg) increased the latencies (11.3 ± 0.5 s) and thresholds (26.3 ± 2.8 g). In contrast to esmolol, dobutamine increased the superoxide dismutase level and decreased the myeloperoxidase, malondialdehyde, and nitric oxide levels in CG-induced inflamed paws. The present results can reveal that β-adrenoreceptors may play a role in inflammatory nociceptive processes, and locally treated β-adrenoreceptor agonists such as dobutamine can be a preferable, appropriate choice for the management of inflammatory nociception due to their preventive and therapeutic effects on CG-induced peripheral inflammatory nociception.
Similar content being viewed by others
References
Berkley, K.J. 1997. Sex differences in pain. Behavioral and Brain Sciences 20: 371–380.
Greenspan, J.D., R.M. Craft, L. LeResche, L. Arendt-Nielsen, K.J. Berkley, R.B. Fillingim, M.S. Gold, A. Holdcroft, S. Lautenbacher, E.A. Mayer, J.S. Mogil, A.Z. Murphy, and R.J. Traub. 2007. Consensus Working Group of the Sex, Gender, and Pain SIG of the IASP. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 132: 26–45.
Andrew, D., and J.D. Greenspan. 1999. Mechanical and heat sensitization of cutaneous nociceptors after peripheral inflammation in the rat. Neurophysiology 82: 2649–2656.
Sessle, B.J. 2001. New insights into peripheral chemical mediators of pain and inflammation. Journal of Orofacial Pain 15: 1–5.
Coutaux, A., F. Adam, J.C. Willer, and D. Le Bars. 2005. Hyperalgesia and allodynia: peripheral mechanisms. Joint, Bone, Spine 72: 359–371.
Millan, M.J. 1999. The induction of pain: an integrative review. Progress in Neurobiology 57: 1–164.
Sawynok, J. 2003. Topical and peripherally acting analgesics. Pharmacological Reviews 55: 1–20.
Chopade, A.R., and W.A. Mulla. 2010. Novel strategies for the treatment of inflammatory hyperalgesia. European Journal of Clinical Pharmacology 66: 429–444.
Oda, A., H. Iida, S. Tanahashi, Y. Osawa, S. Yamaguchi, and S. Dohi. 2007. Effects of alpha2-adrenoceptor agonists on tetrodotoxin-resistant Na+channels in rat dorsal root ganglion neurons. European Journal of Anaesthesiology 24: 934–941.
Uzkeser, H., Cadirci, E., Halici, Z., Odabasoglu, F., Polat, B., Yuksel, T.N., Ozaltin, S., Atalay, F. 2012. Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism. Mediators Inflammation Article ID 438912.
Taira, Y., M. Kakinohana, O. Kakinohana, and Y. Okuda. 1998. ONO 1101, a novel ultra-short acting β1 blocker, can reduce pain behaviour in the rat formalin test. Anesthesiology 89: A1128.
Najafipour, H. 2000. Alteration in alpha- and beta-adrenoceptor profile of rabbit knee joint blood vessels due to acute inflammation. Experimental Physiology 85(3): 267–273.
Chou, M.T., Lo, S.H., Cheng, K.C., Li, Y.X., Chen, L.J., Cheng, J.T. 2012. Activation of β-adrenoceptors by dobutamine may induce a higher expression of peroxisome proliferator-activated receptors δ (PPARδ) in neonatal rat cardiomyocytes. Scientific World Journal, Article ID 248320, 8 pages.
Dacho, C., A. Dacho, A. Geissler, C. Hauser, K. Nowak, and G. Beck. 2013. Catecholamines reduce dose-dependent oedema formation and inflammatory reaction in an isolated rat lung model. In Vivo 27(1): 49–56.
Sum, C.Y., A. Yacobi, R. Kartzinel, H. Stampfli, C.S. Davis, and C.M. Lai. 1983. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Clinical Pharmacology and Therapeutics 34: 427–434.
Volz-Zang, C., B. Eckrich, P. Jahn, B. Schneidrowski, B. Schulte, and D. Palm. 1994. Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties. European Journal of Clinical Pharmacology 46: 399–404.
Tanahashi, S., H. Iida, S. Dohi, A. Oda, Y. Osawa, and S. Yamaguchi. 2009. Comparative effects of ultra-short-acting b1-blockers on voltage-gated tetrodotoxin-resistant Na channels in rat sensory neurons. European Journal of Anaesthesiology 26: 196–200.
Johansen, J.W., R. Flaishon, and P.S. Sebel. 1997. Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia. Anesthesiology 86: 364–371.
Davidson, E.M., M.F. Doursout, P. Szmuk, and J.E. Chelly. 2001. Antinociceptive and cardiovascular properties of esmolol following formalin injection in rats. Canadian Journal of Anaesthesiology 48: 59–64.
Wilson, M.A., and R. Biscardi. 1994. Sex differences in GABA/benzodiazepine receptor changes and corticosterone release after acute stress in rats. Experimental Brain Research 101: 297–306.
Walker, Q.D., C.J. Nelson, D. Smith, and C.M. Kuhn. 2002. Vaginal lavage attenuates cocaine-stimulated activity and establishes place preference in rats. Pharmacology Biochemistry and Behavior 73: 743–52.
Mert, T., I. Gunay, I. Ocal, A.I. Guzel, T.C. Inal, L. Sencar, and S. Polat. 2009. Macrophage depletion delays progression of neuropathic pain in diabetic animals. Naunyn Schmiedebergs Archives Pharmacology 379: 445–452.
Mert, T., Y. Gunes, and I. Gunay. 2013. Comparison of actions of systemically and locally administrated local anaesthetics in diabetic rats with painful neuropathy. Fundamental and Clinical Pharmacology 27: 161–168.
Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.
Fridovich, I. 1974. Superoxide dismutases. Advances in Enzymology and Related Areas of Molecular Biology 41: 35–97.
Bermann, T.E. 1969. Enzyme handbook, 234–235. New York: Springer Verlag.
Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Analytical Biochemistry 126: 131–138.
DeLeo, J.A., and M.D. Rutkowski. 2000. Gender differences in rat neuropathic pain sensitivity is dependent on strain. Neuroscience Letters 282: 197–199.
Mogil, J.S., and M.L. Chanda. 2005. The case for the inclusion of female subjects in basic science studies of pain. Pain 117(1–2): 1–5.
Winter, C.A., E.A. Ristey, and G.W. Nuss. 1962. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proceedings of the Society for Experimental Biology and Medicine 111: 544–547.
Di Rosa, M. 1972. Biological properties of the carrageenan. Journal of Pharmacy and Pharmacology 24: 89–102.
Fecho, K., A.G. Nackley, Y. Wu, and W. Maixner. 2005. Basal and carrageenan-induced pain behavior in Sprague–Dawley, Lewis and Fischer rats. Physiology and Behavior 85: 177–186.
Barrot, M. 2012. Tests and models of nociception and pain in rodents. Neuroscience 211: 39–50.
Treede, R.D., R.A. Meyer, S.N. Raja, and J.N. Campbell. 1992. Peripheral and central mechanisms of cutaneous hyperalgesia. Progress in Neurobiology 38(4): 397–421.
Koltzenburg, M. 2000. Neural mechanisms of cutaneous nociceptive pain. Clinical Journal of Pain 16: 131–138.
Fantone, J.C., and P.A. Ward. 1982. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. American Journal of Pathology 107: 397–418.
Conner, E.M., and M.B. Grisham. 1996. Inflammation, free radicals and antioxidants. Nutrition 12: 274–277.
Davies, K.J.A. 2000. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50: 279–289.
Khattab, M.M. 2006. TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: a key role for superoxide anion. European Journal of Pharmacology 548: 167–173.
Vinegar, R., J.F. Truax, J.L. Selph, P.R. Johnston, A.L. Venable, and K.K. McKenzie. 1987. Pathway to carrageenan-induced inflammation in the hind limb or the rat. Federation Proceedings 46: 118–126.
Sies, H. 1993. Strategies of antioxidant defense. European Journal of Biochemistry 215: 213–219.
McCord, J.M. 2000. The evolution of free radicals and oxidative stress. American Journal of Medicine 108: 652–659.
Nielsen, F., B.B. Mikkelsen, J.B. Nielsen, H.R. Andersen, and P. Grandjean. 1997. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clinical Chemistry 43: 1209–1214.
Wang, Z.Q., F. Porreca, S. Cuzzocrea, K. Galen, R. Lightfoot, E. Masini, C. Muscoli, V. Mollace, M. Ndengele, H. Ischiropoulos, and D. Salvemini. 2004. A newly identified role for superoxide in inflammatory pain. Journal of Pharmacology and Experimental Therapeutics 309: 869–878.
Halici, Z., G.O. Dengiz, F. Odabasoglu, H. Suleyman, E. Cadirci, and M. Halici. 2007. Amiadorane has anti-inflammatory and antioxidative properties: an experimental study in rats with carrageenan-induced paw edema. European Journal of Pharmacology 566: 215–221.
Moncada, S., R.M.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43: 109–142.
Salvemini, D., Z.Q. Wang, D.M. Wyatt, M.H. Bourdon, P.T. Marino, and M.G. Currie. 1996. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. British Journal of Pharmacology 118: 829–838.
Omote, K., K. Hazama, T. Kawamata, Y. Nakayaka, M. Toriyabe, and A. Namiki. 2001. Peripheral nitric oxide in carrageenan- induced inflammation. Brain Research 912: 171–175.
Wiest, D. 1995. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clinical Pharmacokinetics 28(3): 190–202.
Barnes, P.J. 1993. Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells. Life Science 52: 2101–2109.
Khasar, S.G., G. McCarter, and J.D. Levine. 1999. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. Journal of Neurophysiology 81: 1104–1112.
Acknowledgments
This study was supported by the Kahramanmaras Sutcu Imam University Research Foundation (2012/2-12 M).
Conflict of Interest
The authors state no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mert, T., Tugtag, B., Kilinc, M. et al. Preventive and Therapeutic Effects of a Beta Adrenoreceptor Agonist, Dobutamine, in Carrageenan-Induced Inflammatory Nociception in Rats. Inflammation 37, 1814–1825 (2014). https://doi.org/10.1007/s10753-014-9912-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-014-9912-3